← Evidence map

ArticleBMC neurology2014

PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with 18F-AV-133 (florbenazine) in patients with Alzheimer's disease and Lewy body disorders.

Andrew Siderowf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

18 papers cite it

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this paperpooled itcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 24716655